Jafron Biomedical Co., Ltd. was established in 1989. It is mainly engaged in R&D, production and marketing of biomaterials and medical devices. As an A-shared GEM listed corporation, Jafron is a leading enterprise in Chinese blood purification industry. In 2009, Jafron won second prize of National Scientific and Technological Progress Award and was listed in Forbes of Chinese Potential Enterprises in 2010 & 2011 successively. Besides, Jafron was identified as “Key High-tech Enterprise of National Torch Program” in 2011 and owns CE Certification, ISO International Quality Certification as well as China GMP National Certification. It undertakes two State New Key Product Projects and three China National Torch Plan Projects. Besides, Jafron was authorized by the Chinese government to set up Guangdong Engineering Research Center (ERC). Because of great capability of R&D, production as well as national sales network, our products have reached international advanced level. HA series hemoperfusion cartridge, BS bilirubin adsorption column and DNA immunoadsorption column, as the main products of Jafron, have leading market shares in blood purification field in China. In 2015, Jafron head office (Jafron Tech Park) with R&D, manufacturing base, market center was successfully set up in Zhuhai city. In 2020, Jafron will develop into “a professional provider of comprehensive solutions for blood purification” and explore other biomedical fields positively to realize the prospect of becoming the group corporation with world-leading high-tech medical technology. We firmly believe that the success is based on the combination of high-quality products, high-quality talents as well as high-quality service. With great appreciation of supports and trust from experts, doctors, patients and our business partners, Jafron will not stop striving for the global human healthy career.